Abstract
Under the influence of the epidemic and the general economic environment, China's biopharmaceutical industry is facing opportunities and challenges. In this paper, we take the biopharmaceutical industry as the research object, and construct a financial performance evaluation model by factor analysis of 8 financial indicators that reflect the comprehensive ability of solvency, operating ability, profitability and development ability of 10 selected biopharmaceutical industries through stata software, evaluate their financial performance and make a comprehensive analysis of the financial performance of Sinobioway Biomedicine, and finally propose countermeasures and suggestions.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
